MORE VIDEOS
Udforsk mere

Seneste videoer

PILES BAVASIR Vs ANAL CANCER - DIFFERENCE - Symptoms बवासीर है या कैंसर ?
PILES BAVASIR Vs ANAL CANCER - DIFFERENCE - Symptoms बवासीर है या कैंसर ? administrator 2 Visninger • 2 flere år siden

Difference in Piles Bavasir Hemmorhoids & Anal cancer or rectum colon carcinoma ? Learn about this danger symptoms & why treatment by doctor is necessary for best results & safety ? Listen from top proctologist in India about Piles & Colon Cancer

#Proctologist #Cancer #Piles #Bavasir #bawasir #hemmorhoids #analcancer #rectalcancer #rectum #ColonCancer #Treatment #HealthTips #Colonoscopy #colon #Health #AnalCanal #YourSurgeon #Surat #Gujarat #Intestine #bleeding
What is anal cancer?
What is anal cancer? administrator 1 Visninger • 2 flere år siden

For additional information, visit https://amzn.to/3bMD4mO Learn the meaning of anal cancer through this video. Anal cancer is a rare type of cancer starting in the anus. Anal cancer can start in any part of the anus. The anus is the opening at the very end of the large bowel. In men, anal margin tumors are more common, while in women, cancers that start higher up in the anal canal are more common. In most cases, cancers of the anal margin look more like normal cells, and are called well differentiated tumors. Different types of anal cancer exist, which means that your type depends on the type of cell in which the cancer starts. This can determine the treatment options.

Squamous cell cancers are very common, and start in squamous cells that make up the lining of the anal canal. The lining of the transitional zone is made up of both glandular and squamous cells. The mucus which helps stools (feces) to smoothly pass through the anus is made by glandular cells, and on very rare cases, anal cancer can develop from the glandular cells. This is called adenocarcinoma of the anus. Another rare type of anal cancer is melanoma, starting in cells in the skin called melanocytes.

For more information, please visit http://www.ecancertips.com

Listen to your body: A young-onset colorectal cancer patient's journey
Listen to your body: A young-onset colorectal cancer patient's journey administrator 1 Visninger • 2 flere år siden

At the age of 29, newlywed Marine Patrick Beauregard was diagnosed with stage 4 colon cancer. In this clip, he shares his initial reaction to his diagnosis and why you shouldn’t ignore changes in your body. Watch the full “Too Young for This Sh*t” webcast hosted by Congressional Families Cancer Prevention Program at https://www.youtube.com/watch?v=ZnNxktcdDGM and learn more about the Prevent Cancer Foundation’s campaign to spread awareness of early-onset colorectal cancer at http://tooyoungforthis.org

Study shows better option for treatment of inoperable anal cancer
Study shows better option for treatment of inoperable anal cancer administrator 1 Visninger • 2 flere år siden

#India #Delhi #Cancer #ClinicalOncology #AnalCancer

New Delhi, June 26 (ANI): A new study has suggested that people with inoperable anal cancer treated with carboplatin-paclitaxel had fewer complications and lived longer than those who received another chemotherapy that has been more often administered.

--------------------------------------
Subscribe now! Enjoy and stay connected with us!!
☛ Subscribe ANI News channel: https://bit.ly/2UV4ygi
☛ Visit our Official website: https://www.aninews.in/
☛ Follow ANI News: https://twitter.com/ANI
☛ Like us: https://www.facebook.com/ANINEWS.IN
☛ Email to Shrawan K Poddar: shrawankp@aniin.com
☛ Copyrights © All Rights Reserved ANI Media Pvt Ltd.

Baseline diffusion-weighted MRI to predict anal cancer recurrence
Baseline diffusion-weighted MRI to predict anal cancer recurrence administrator 1 Visninger • 2 flere år siden

Kasia Owczarczyk, MD, MRCP, FRCR, of King’s College London, London, UK, discusses how baseline diffusion-weighted magnetic resonance imaging (MRI) features can predict recurrence of anal squamous cell carcinoma following chemoradiotherapy. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).
Organ preservation for rectal cancer: long-course chemoradiation vs short-course radiation therapy
Organ preservation for rectal cancer: long-course chemoradiation vs short-course radiation therapy administrator 0 Visninger • 2 flere år siden

Paul Bernard Romesser, MD, Memorial Sloan Kettering Cancer Center, New York, NY, provides an overview of an investigation into long-course chemoradiation versus short-course radiation therapy for organ preservation with total neoadjuvant therapy for rectal cancer. Both long-course chemoradiation versus short-course radiation therapy achieved a complete clinical response of 46%, however, there was a higher rate of organ preservation at 2 years for patients who had long-course chemoradiation compared to short-course radiation. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Gastrointestinal Cancers (GI) Symposium in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Tips on spotting colon cancer
Tips on spotting colon cancer administrator 1 Visninger • 2 flere år siden

March is Colorectal Cancer Month. In these video soundbites, Dr. Erin O. Lange, a UW Medicine colorectal surgeon, talks about symptoms to watch for, no matter your age.
For more video soundbites, please visit the UW Medicine Newsroom at https://newsroom.uw.edu/

Non-operative management of rectal cancer
Non-operative management of rectal cancer administrator 5 Visninger • 2 flere år siden

Tsuyoshi Konishi, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the latest in non-surgical treatment strategies for patients with rectal cancer, including accurate monitoring of clinical complete response after neoadjuvant therapy. Dr Konishi additionally highlights the need for monitoring patients post-surgery, where the risk of regrowth is high, as well as salvage surgery in patients where regrowth happens. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Gastrointestinal Cancers (GI) Symposium in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
What is new in anal cancer in the last 12 months?
What is new in anal cancer in the last 12 months? administrator 1 Visninger • 2 flere år siden

Earn CME for related activities: https://www.naccme.com/oln

In this presentation from the ESMO 20th World Congress on Gastrointestinal Cancer, Dr. Michel Ducreux discusses the latest advances in the treatment of anal cancer.

© 2018 Imedex, LLC.

Non-surgical treatment options for patients with rectal cancer
Non-surgical treatment options for patients with rectal cancer administrator 18 Visninger • 2 flere år siden

Surgery is the standard of care for rectal cancer, and radiotherapy is typically given in advanced rectal cancer. Arthur Myint, MBBS, FRRP, FFRCS, FRCR, FICS, The Clatterbridge Cancer Centre, Cambridge, UK, provides an overview of novel strategies that minimize the use of surgery. Previous research has determined that approximately half of patients receiving external beam radiotherapy (EBRT) alone will progress. Findings from the Phase III OPERA trial (NCT02505750) demonstrated that additional contact radiotherapy enhances organ preservation rates. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Gastrointestinal Cancers (GI) Symposium in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Showing 3433 out of 3434